Healthcare Innovation

Tampa General CEO Couris Named to Florida 500 for Sixth Year

Image
Tampa General CEO Couris Named to Florida 500 for Sixth Year

TAMPA – October 29, 2026 -- John Couris, president and CEO of Florida Health Sciences Center | Tampa General Hospital (TGH), earned a place on Florida Trend's 2026 "Florida 500" list for the sixth consecutive year, and four other TGH-linked leaders joined him on the list.

The other honorees are Board Chair Blake Casper (CEO of Caspers Company), Vice Chair and Corporate Secretary Gregory Celestan (president of Celestar, LLC), and Immediate Past Board and Governance Chair Drew Graham (managing partner of Ballast Point Ventures). Jennifer Crabtree, president of the Tampa Medical & Research District (TMRD) and a TGH senior vice president, is the fifth. The list covers more than 60 business categories. Florida Trend editors select honorees through independent research and interviews, and advertising plays no role.

IMDA, NUH Sign MOI Opening Hospital Challenges to 21,000 Innovators

Image
IMDA, NUH Sign MOI Opening Hospital Challenges to 21,000 Innovators

SINGAPORE – October 29, 2026 -- Singapore's Infocomm Media Development Authority (IMDA) and the National University Hospital (NUH) have signed a Memorandum of Intent giving technology firms direct access to hospital-defined problems, in IMDA's first Open Innovation Platform (OIP) partnership with a public healthcare institution.

NUH will participate through its Kent Ridge Office of Innovation (KROI), established in April 2024. The deal connects the hospital's clinical and operational teams with the OIP network of about 21,000 innovators and solution providers, spanning startups, technology firms and research institutions. IMDA frames the tie-up as support for Singapore's National AI Strategy in key sectors such as healthcare.

ASA Forms Advisory Committee of Seven Dermatology Leaders

Image
ASA Forms Advisory Committee of Seven Dermatology Leaders

New York – October 15, 2026 -- The American Skin Association (ASA), which has awarded more than $50 million in research grants, has formed a seven-member Emerging Dermatology Leaders Advisory Committee to guide its research priorities, pipeline therapy focus and patient education programs.

Mount Sinai's Nicholas Brownstone chairs the new ASA committee

Nicholas Brownstone, MD, Assistant Professor of Dermatology at the Kimberly and Eric J. Waldman Department of Dermatology at the Icahn School of Medicine at Mount Sinai, will chair the panel. His research covers psoriasis, phototherapy, eczema, hidradenitis suppurativa, psychodermatology and skin cancer. He has also hosted ASA's podcast series, The SKINsight Podcast: A Patient's Guide.

Midea Completes Control Acquisition of Italy's Esaote

Image
Midea Completes Control Acquisition of Italy's Esaote

Genoa – – October 09, 2026 -- Midea Group has completed the acquisition of a controlling stake in Esaote S.p.A., the Italian medical imaging maker that posted fiscal 2025 revenues of EUR 267 million, 70% of them from international markets.

Esaote joins Midea Healthcare as an independent company

Esaote becomes part of Midea's Healthcare Division but will continue to operate as an independent global medical equipment company. It stays headquartered in Genoa, with R&D and manufacturing facilities in Italy and the Netherlands. Franco Fontana remains CEO, confirmed by the new shareholders.

Midea's DR, MRI, CT and DSA lines meet Esaote's ultrasound and open MRI strengths

Midea's portfolio covers DR, high-field MRI, CT and DSA. Esaote contributes premium-brand strengths in ultrasound, open and dedicated MRI systems and medical IT solutions. Esaote ranks among the top ten global manufacturers of ultrasound and of open and dedicated MRI.

Portland Research Site Marks 50 Years Behind Every Alzheimer's Drug Class

Image
Portland Research Site Marks 50 Years Behind Every Alzheimer's Drug Class

Portland – October 06, 2026 -- Headlands Research - Summit Portland is marking 50 years of operation in 2026, having contributed clinical research to every FDA-approved class of Alzheimer's disease medication brought to market since 1993. The site, founded in 1976, has conducted more than 500 clinical trials in partnership with pharmaceutical companies and contract research organizations (CROs).

Function Health Names Ex-Instagram, Uber, Spotify Exec Taj Alavi as First CMO

Image
Function Health Names Ex-Instagram, Uber, Spotify Exec Taj Alavi as First CMO

Austin – October 05, 2026 -- Function Health has appointed Taj Alavi as its first Chief Marketing Officer, tasking the former Instagram, Uber and Spotify executive with scaling consumer adoption of its preventive health testing platform.

Alavi brings three consumer-tech scale-up track records to a health startup

At Instagram, Alavi led global brand marketing and launched the Stories feature as the platform grew from 300 million to 1 billion users. She later ran global brand and creative at Uber before serving as Global Head of Marketing at Spotify, overseeing growth, product and marketing for a $13 billion business spanning music, podcasts and audiobooks. She most recently consulted for Neko Health, a European health-screening company.

Global Coalition Launches 30x30x50 Challenge to Cut Stroke, Expand Screening

New York – October 05, 2026 -- A new multisector coalition launched the 30x30x50 Brain Challenge, pledging to cut stroke incidence by 30 percent and increase primary-care cognitive screening by 50 percent across 30 global cities by 2031.

Atria-coordinated coalition unites pharma, tech and the UN behind brain health delivery

The International Brain Health Coalition (IBC), coordinated by the Atria Research and Global Health Institute (ARGHI), brings together patients, multilateral institutions including the United Nations, and organizations spanning medicine, technology, and finance. Collaborators include Eli Lilly and Company, Bristol Myers Squibb, Microsoft, the Royal Bank of Canada, the American Heart Association, UN Women, Western University, and the AI-Mind Institute in Norway.

108 BioCapital Leads $4M Round in SedMed Toilet Lift Maker

Image
108 BioCapital Leads $4M Round in SedMed Toilet Lift Maker

Danbury, Conn. – October 01, 2026 -- 108 BioCapital is leading a $4 million investment in SedMed, Inc., a medical device maker whose non-electric toilet lift is already used across more than 40 hospital systems.

Funding targets commercial expansion and hospital studies

The capital will accelerate SedMed's commercial growth, expand distribution and channel partnerships, advance its intellectual property portfolio, and fund additional hospital-based studies, the company said. SedMed's flagship product attaches to most standard toilets and provides adjustable sit-to-stand assistance without electricity, batteries or bathroom remodeling, targeting older adults and individuals with mobility limitations.

NYU Langone AI Tool Closes Radiology Training Gaps With 90% Accuracy

Image
NYU Langone AI Tool Closes Radiology Training Gaps With 90% Accuracy

New York – September 30, 2026 -- Researchers at NYU Langone Health have built an artificial intelligence system that tracks the daily case exposure of radiology residents and flags missing pathologies with more than 90 percent accuracy, according to a study published online in Academic Radiology.

AI system pinpoints training gaps that traditional case logs miss

The tool monitors which conditions residents encounter during clinical rotations and automatically identifies underexposed pathologies, then assigns supplemental teaching cases to close the gap. Study author Vinay Prabhu, an associate professor in NYU Grossman School of Medicine's Department of Radiology, said residents seeing 30 cases in a day typically encounter 29 routine exams and only one uncommon condition, leaving gaps in exposure to rarer diseases they will face throughout their careers.